R. Winnenburg

发表

Feasibility of Prioritizing Drug–Drug-Event Associations Found in Electronic Health Records

George Hripcsak, Michel Dumontier, Alison Callahan, 2015, Drug Safety.

Exploring adverse drug events at the class level

Olivier Bodenreider, Alfred Sorbello, Rainer Winnenburg, 2015, J. Biomed. Semant..

Eliciting the Intension of Drug Value Sets – Principles and Quality Assurance Applications

Olivier Bodenreider, Nathan J. Bahr, Rainer Winnenburg, 2018, MedInfo.

Drug Terminology and Ontology Integration, Dissemination, Quality Assurance and Applications A Report to the Board of Scientific Counselors September 2014

O. Bodenreider, R. Winnenburg, 2014 .

Mapping drug entities between the European and American standards, ATC and RxNorm

O. Bodenreider, R. Winnenburg, 2012 .

Improved mutation tagging with gene identifiers applied to membrane protein stability prediction

Michael Schroeder, Conrad Plake, Rainer Winnenburg, 2009, BMC Bioinformatics.

Stabilizing Regions in Membrane Proteins

S. Mohanty, D. Labudde, W. Nadler, 2008 .

Data from "A Time-indexed Reference Standard of Adverse Drug Reactions"

Olivier Bodenreider, Ryen W. White, Eric Horvitz, 2014 .

PHI-base: a new database for pathogen host interactions

Christopher J. Rawlings, Kim E. Hammond-Kosack, Martin Urban, 2005, Nucleic Acids Res..

PHI-base update: additions to the pathogen–host interaction database

Christopher J. Rawlings, Kim E. Hammond-Kosack, Martin Urban, 2007, Nucleic Acids Res..

The digital revolution in phenotyping

Olivier Bodenreider, Michel Dumontier, Hongfang Liu, 2015, Briefings Bioinform..

Facts from text: can text mining help to scale-up high-quality manual curation of gene products with ontologies?

Michael Schroeder, Thomas Wächter, Conrad Plake, 2008, Briefings Bioinform..

Using description logics to evaluate the consistency of drug-class membership relations in NDF-RT

O. Bodenreider, J. Mortensen, R. Winnenburg, 2015, J. Biomed. Semant..

Interpretation of biological experiments changes with evolution of the Gene Ontology and its annotations

Dominique T. Alessi, N. Shah, Francesco Vallania, 2018, Scientific Reports.

Interpretation of biological experiments changes with evolution of the Gene Ontology and its annotations

Mark A. Musen, Winston Haynes, Francesco Vallania, 2017, Scientific Reports.

Implementation and relevance of FAIR data principles in biopharmaceutical R&D.

Ian Smith, Andrea Splendiani, Jan Taubert, 2019, Drug discovery today.

A method for systematic discovery of adverse drug events from clinical notes

Guan Wang, Nigam H. Shah, Kenneth Jung, 2015, J. Am. Medical Informatics Assoc..

GoGene: gene annotation in the fast lane

Michael Schroeder, Jörg Hakenberg, Conrad Plake, 2009, Nucleic Acids Res..

SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions

Michael Schroeder, Christian Senger, Stefan Günther, 2009, Nucleic Acids Res..

A time-indexed reference standard of adverse drug reactions

Olivier Bodenreider, Ryen W. White, William DuMouchel, 2014, Scientific Data.

Coverage of Phenotypes in Standard Terminologies

Olivier Bodenreider, Rainer Winnenburg, O. Bodenreider, 2014 .

The pathogen-host interactions database (PHI-base) provides insights into generic and novel themes of pathogenicity.

Rainer Winnenburg, Jacob Koehler, Chris Rawlings, 2006, Molecular plant-microbe interactions : MPMI.

MeMotif: a database of linear motifs in α-helical transmembrane proteins

Michael Schroeder, Andreas Henschel, Christof Winter, 2009, Nucleic Acids Res..

Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies

Olivier Bodenreider, Rave Harpaz, Anna Ripple, 2015, J. Biomed. Informatics.

Evaluating the consistency of inferred drug-class membership re- lations in NDF-RT

Olivier Bodenreider, Rainer Winnenburg, O. Bodenreider, 2014 .

Aligning Pharmacologic Classes Between MeSH and ATC

Olivier Bodenreider, Laritza Rodriguez, Alfred Sorbello, 2013, VDOS+DO@ICBO.

Exploring Pharmacoepidemiologic Groupings of Drugs from a Clinical Perspective

Olivier Bodenreider, Rainer Winnenburg, O. Bodenreider, 2013, MedInfo.

Issues in Creating and Maintaining Value Sets for Clinical Quality Measures

Olivier Bodenreider, Rainer Winnenburg, O. Bodenreider, 2012, AMIA.

The NLM Value Set Authority Center

Olivier Bodenreider, Robert C. McClure, Rainer Winnenburg, 2013, MedInfo.

The OXL format for the exchange of integrated datasets

Jan Taubert, Stephan Philippi, Rainer Winnenburg, 2007, J. Integr. Bioinform..

U-Index, a dataset and an impact metric for informatics tools and databases

Alison Callahan, Nigam H Shah, Rainer Winnenburg, 2018, Scientific Data.

Extending the coverage of phenotypes in SNOMED CT through post-coordination

Olivier Bodenreider, Ferdinand Dhombres, Rainer Winnenburg, 2018, MedInfo.

Metrics for assessing the quality of value sets in clinical quality measures

Olivier Bodenreider, Rainer Winnenburg, O. Bodenreider, 2013, AMIA.

Toward multimodal signal detection of adverse drug reactions

Olivier Bodenreider, Ryen W. White, Eric Horvitz, 2017, J. Biomed. Informatics.

Drug repurposing by integrated literature mining and drug-gene-disease triangulation.

Peng Sun, Jan Baumbach, Jiong Guo, 2017, Drug discovery today.

Generalized enrichment analysis improves the detection of adverse drug events from the biomedical literature

N. Shah, R. Winnenburg, 2016, BMC Bioinformatics.